Dr PRADEYROL is the Executive Chairman and Founder of Pradeyrol Développement, a family office actively investing in new technologies. With participations in a dozen of Biotech companies in France and in the US, Pradeyrol Développement is highly interested in immunology and preventive medicines, in vaccines, drugs and diagnostics.
• Chairman and CEO, IMAXIO (2018 – current)
• Executive Chairman and founder of Pradeyrol Développement (2007-current)
• Founder and manager of CHP group, a leading French group of private clinics – acquired by Blackstone in 2007
• Medical Degree from the University of Clermont-Ferrand